Listar INIBIC-EC-Artigos por data de publicación
Mostrando ítems 1-20 de 25
-
Worse outcome in stroke patients treated with rt-PA without early reperfusion: associated factors
(Springer Nature, 2017-11-07)[Abstract] Based on preclinical studies suggesting that recombinant tissue plasminogen activator (rt-PA) may promote ischemic brain injuries, we investigated in patients the possible risk of worse clinical outcome after ... -
Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease
(Elsevier, 2019-08-11)[Abstract] Introduction: There is little control of cardiovascular (CV) risk factors in secondary prevention after an ischaemic stroke, in part due to a lack of adherence to treatment. The CV polypill may contribute ... -
Association of high serum levels of growth factors with good outcome in ischemic stroke: a multicenter study
(Springer Nature, 2019-11-25)[Abstract] The main objective of this research work was to study the association of serum levels of growth factors (GF) and SDF-1α with the functional outcome and reduction of lesion volume in ischemic stroke patients. In ... -
Will neurological care change over the next 5 years due to the COVID-19 pandemic?: key informant consensus survey
(Elsevier, 2020-05-21)[Abstract] Introduction. The COVID-19 pandemic will give rise to long-term changes in neurological care, which are not easily predictable. Material and methods. A key informant survey was used to enquire about the changes ... -
Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain
(Sage, 2020-06-11)[Abstract] Background and purpose: Spain has been one of the countries heavily stricken by COVID-19. But this epidemic has not affected all regions equally. We analyzed the impact of the COVID-19 pandemic on hospital ... -
Prevención de ictus en pacientes con diabetes mellitus tipo 2 o prediabetes: recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología
(Elsevier, 2020-09-24)[Resumen] Objetivo. Actualizar las recomendaciones de la Sociedad Española de Neurología para la prevención del ictus en pacientes con DM-2 o prediabetes, analizando las evidencias disponibles sobre el efecto del control ... -
Oral anticoagulation and risk of symptomatic hemorrhagic transformation in stroke patients treated with mechanical thrombectomy: data from the nordictus registry
(Frontiers, 2020-11-26)[Abstract] Introduction: We aimed to evaluate if prior oral anticoagulation (OAC) and its type determines a greater risk of symptomatic hemorrhagic transformation in patients with acute ischemic stroke (AIS) subjected to ... -
Stroke care during the COVID-19 outbreak in Spain: the experience of spanish stroke units
(BMJ, 2020-12-04)[Abstract] Background and purpose: Spain has been heavily affected by COVID-19. Reallocation of resources for managing the outbreak might have caused a disruption in stroke care. This study analyses the impact on stroke ... -
Recommendations of the Spanish Society of Neurology for the prevention of stroke: interventions on lifestyle and air pollution
(Elsevier, 2021-03-27)[Abstract] Objective: To update the recommendations of the Spanish Society of Neurology regarding lifestyle interventions for stroke prevention. Development: We reviewed the most recent studies related to lifestyle ... -
Stroke prevention in patients with arterial hypertension: recommendations of the Spanish Society of Neurology's Stroke Study Group
(Elsevier, 2021-04-23)[Abstract] Objective: To update the recommendations of the Spanish Society of Neurology on primary and secondary stroke prevention in patients with arterial hypertension. Development: We proposed several questions ... -
RP11-362K2.2:RP11-767I20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma: a GWAS meta-analysis
(MDPI, 2021-07-16)[Abstract] Stroke is one of the most common causes of death and disability. Reperfusion therapies are the only treatment available during the acute phase of stroke. Due to recent clinical trials, these therapies may increase ... -
Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: consensus document and practice guidance
(Elsevier, 2021-12-11)[Abstract] Introduction: Patients with history of stroke or transient ischaemic attack present considerable risk of future vascular events. Reducing levels of low-density lipoprotein (LDL) cholesterol decreases the ... -
Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology
(Elsevier, 2022-01)[Abstract] Objective: We present an update of the Spanish Society of Neurology's recommendations for prevention of both primary and secondary stroke in patients with dyslipidaemia. Development: We performed a ... -
Síndrome de trombosis con trombocitopenia asociado a vacunas de adenovirus frente a la COVID-19: epidemiología y presentación clínica de la serie española
(Elsevier, 2022-05-23)[Resumen] Introducción. Se describen las características epidemiológicas y clínicas de los casos de síndrome de trombosis con trombocitopenia (STT) notificados en España. Métodos. Se incluyeron los casos de trombosis ... -
Retos principales a corto y medio plazo en el ictus
(Permanyer, 2022-05-28) -
Comentario del CEIPV a las nuevas Guías Europeas de Prevención Cardiovascular 2021
(Elsevier en nombre de la Sociedad Española de Nefrología, 2022-06-10)[Resumen] Presentamos la adaptación española de las Guías Europeas de Prevención Cardiovascular 2021. En esta actualización además del abordaje individual, se pone mucho más énfasis en las políticas sanitarias como estrategia ... -
Characteristics of stroke units and stroke teams in Spain in 2018: Pre2Ictus project
(Elsevier, 2022-06-30)[Abstract] Introduction: The aim of this work is to describe the characteristics of stroke units and stroke teams in Spain. Method: We performed a cross-sectional study based on an ad hoc questionnaire designed by ... -
Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: protocol of the Reality study
(Frontiers, 2022-08-04)[Abstract] Background: Atherosclerotic cardiovascular diseases (ASCVD) and dyslipidemia are associated to a higher risk of cardiovascular events, mortality, use of healthcare resources and costs. In Spain, the evidence ... -
Documento de consenso de la Sociedad Española de Ginecología y Obstetricia (SEGO) y el Comité Español Interdisciplinario para la Prevención Vascular (CEIPV): ventana de oportunidad: prevención del riesgo vascular en la mujer: resultados adversos del embarazo y riesgo de enfermedad vascular
(Sociedad Española de Ginecología y Obstetricia (SEGO), 2023)[Resumen] Este documento resume la evidencia que existe entre los resultados adversos del embarazo (RAE), tales como son los trastornos hipertensivos, el parto pretérmino, la diabetes gestacional, los defectos en el ... -
Liquid chromatography fingerprint analysis of released compounds in plasmas samples of stroke patients after thrombolytic treatment
(MDPI, 2023-01-05)[Abstract] Plasma samples obtained from stroke patients treated with recombinant tissue-type plasminogen activator (rt-PA) and not treated with rt-PA were evaluated with different HPLC methodologies to obtain information ...
